About This Tool

The Atezolizumab (Tecentriq) Dosing Schedule Calculator is a clinical support tool designed for healthcare professionals to project administration dates for patients receiving atezolizumab. By inputting a start date and selecting a standard regimen, the calculator generates a forward-looking schedule to assist with clinic management, patient communication, and treatment planning.

Outputs Explained

Upon calculation, the tool generates a detailed schedule presented in a clear, tabular format. Each row corresponds to a treatment cycle and includes:

• Cycle: The sequential number of the infusion cycle (e.g., 1, 2, 3).
• Planned Date: The projected calendar date for the atezolizumab administration, calculated based on the selected dosing interval.
• Day: The corresponding day of the week for the planned date (e.g., Monday, Tuesday). Dates falling on a weekend are highlighted for scheduling awareness.
• Notes: An editable field to add patient-specific comments, such as confirmation of appointment or notes on dose adjustments, for personal record-keeping or printing.

How to Use the Calculator

To generate a dosing schedule, follow these steps:

1. Patient Identifier (Optional): Enter a non-identifiable reference, like patient initials or a medical record number (MRN), for easy identification of the generated schedule. Do not enter Protected Health Information (PHI).
2. Dosing Regimen: Select the appropriate weight-independent, fixed-dosing regimen from the dropdown menu (e.g., every 2, 3, 4, or 6 weeks).
3. Treatment Start Date (Cycle 1): Use the date picker to select the day the first dose of atezolizumab is administered.
4. Number of Cycles to Calculate: Input the desired number of cycles to project forward (from 1 to 52).
5. Generate Schedule: Click the "Generate Schedule" button to produce the table. The "Reset" button will clear all fields to their default state.

Dosing Overview

Atezolizumab is administered as an intravenous (IV) infusion. The recommended dosage for approved indications is based on one of the following fixed-dose, weight-independent regimens. The choice of regimen may depend on the specific indication and combination agents. Always consult the full prescribing information for indication-specific dosing.

Switching Between Dosing Schedules

According to the prescribing information, patients who have started on a 2-, 3-, or 4-week cycle may be switched to the 6-week (1875 mg) cycle if appropriate. The first 1875 mg dose should be administered at the time of the next scheduled dose. Clinical judgment should be used when considering a switch. This calculator does not model a switch in regimen; a new schedule should be generated if a patient's dosing frequency is changed.

Managing a Missed Dose

If a planned dose of atezolizumab is missed, it should be administered as soon as possible. The administration schedule should then be adjusted to maintain the original dosing interval (e.g., every 2, 3, 4, or 6 weeks) from the date the missed dose was given. This calculator should be rerun with the new administration date as the start of the next cycle to ensure the schedule remains accurate. Consult the official prescribing information for complete guidance.

Safety Alerts & Disclaimer

Frequently Asked Questions (FAQ)

1. What should I do if a calculated date falls on a weekend or holiday?

The calculator highlights weekend dates in the output table. The treating institution's scheduling policy should be followed. Typically, the infusion would be scheduled for the preceding Friday or the following Monday, as clinically appropriate. The note field can be used to document the rescheduled date.

2. Does the tool account for dose delays or interruptions?

No. The calculator generates an ideal schedule based on a fixed interval. If a dose is delayed, you should generate a new schedule starting from the date the delayed dose is actually administered to ensure all subsequent dates are correct.

3. Can I export or print the schedule?

Yes. After generating the schedule, use the "Copy Table" button. This copies the schedule data in a tab-separated format that can be pasted directly into a spreadsheet application like Microsoft Excel or Google Sheets for printing or further customization.

4. Is the patient identifier I enter saved or transmitted anywhere?

No. The calculator operates entirely within your browser. No data, including the optional patient identifier, is stored, saved, or transmitted to any server. It is used for display purposes only.

5. Why is the maximum number of cycles limited to 52?

The limit is set to provide a practical, long-term projection (equivalent to one to four years, depending on the regimen) while maintaining tool performance and readability.

6. What do the abbreviations Q2W, Q3W, Q4W, and Q6W mean?

These are common medical abbreviations for dosing frequencies: Q2W (every 2 weeks), Q3W (every 3 weeks), Q4W (every 4 weeks), and Q6W (every 6 weeks).

7. Does this calculator use the correct doses for all indications?

The calculator uses the four standard weight-independent, fixed-dose regimens approved for atezolizumab. However, the appropriate dose and schedule depend on the specific cancer type and whether it's used as a monotherapy or in combination. Always verify with the latest prescribing information for the specific indication.

8. Can I use this calculator for pediatric patients?

The safety and effectiveness of atezolizumab have been established in some pediatric patients for specific indications. However, dosing may be weight-based (mg/kg) for pediatric patients under certain conditions. This calculator is designed for the fixed-dose adult regimens only. Consult the PI for pediatric dosing information.